ZILLOW GROUP INC - C (Z) Fundamental Analysis & Valuation

NASDAQ:ZUS98954M2008

Current stock price

40.44 USD
-1.42 (-3.39%)
At close:
40.56 USD
+0.12 (+0.3%)
After Hours:

This Z fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. Z Profitability Analysis

1.1 Basic Checks

  • In the past year Z was profitable.
  • In the past year Z had a positive cash flow from operations.
  • In the past 5 years Z reported 4 times negative net income.
  • Of the past 5 years Z 4 years had a positive operating cash flow.
Z Yearly Net Income VS EBIT VS OCF VS FCFZ Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B

1.2 Ratios

  • Z has a Return On Assets of 0.40%. This is comparable to the rest of the industry: Z outperforms 53.23% of its industry peers.
  • With a Return On Equity value of 0.47%, Z perfoms like the industry average, outperforming 56.45% of the companies in the same industry.
Industry RankSector Rank
ROA 0.4%
ROE 0.47%
ROIC N/A
ROA(3y)-1.3%
ROA(5y)-2.07%
ROE(3y)-1.78%
ROE(5y)-3.49%
ROIC(3y)N/A
ROIC(5y)N/A
Z Yearly ROA, ROE, ROICZ Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 -2 -4 -6 -8

1.3 Margins

  • Z has a Profit Margin (0.89%) which is in line with its industry peers.
  • Looking at the Gross Margin, with a value of 74.14%, Z belongs to the top of the industry, outperforming 88.71% of the companies in the same industry.
  • Z's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM N/A
PM (TTM) 0.89%
GM 74.14%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y9.35%
Z Yearly Profit, Operating, Gross MarginsZ Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 -20 40 60 80

8

2. Z Health Analysis

2.1 Basic Checks

  • Z does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • Compared to 1 year ago, Z has less shares outstanding
  • Z has about the same amout of shares outstanding than it did 5 years ago.
  • Z has a better debt/assets ratio than last year.
Z Yearly Shares OutstandingZ Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M
Z Yearly Total Debt VS Total AssetsZ Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B 8B 10B

2.2 Solvency

  • An Altman-Z score of 7.55 indicates that Z is not in any danger for bankruptcy at the moment.
  • Z has a better Altman-Z score (7.55) than 88.71% of its industry peers.
  • Z has a debt to FCF ratio of 3.60. This is a good value and a sign of high solvency as Z would need 3.60 years to pay back of all of its debts.
  • The Debt to FCF ratio of Z (3.60) is better than 75.81% of its industry peers.
  • A Debt/Equity ratio of 0.07 indicates that Z is not too dependend on debt financing.
  • With a decent Debt to Equity ratio value of 0.07, Z is doing good in the industry, outperforming 77.42% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 3.6
Altman-Z 7.55
ROIC/WACCN/A
WACC8.81%
Z Yearly LT Debt VS Equity VS FCFZ Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 2B -2B 4B

2.3 Liquidity

  • Z has a Current Ratio of 3.13. This indicates that Z is financially healthy and has no problem in meeting its short term obligations.
  • Z's Current ratio of 3.13 is fine compared to the rest of the industry. Z outperforms 72.58% of its industry peers.
  • Z has a Quick Ratio of 3.13. This indicates that Z is financially healthy and has no problem in meeting its short term obligations.
  • Z has a better Quick ratio (3.13) than 75.81% of its industry peers.
Industry RankSector Rank
Current Ratio 3.13
Quick Ratio 3.13
Z Yearly Current Assets VS Current LiabilitesZ Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2B 4B 6B

6

3. Z Growth Analysis

3.1 Past

  • Z shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 19.71%, which is quite good.
  • The Earnings Per Share has been growing by 35.43% on average over the past years. This is a very strong growth
  • Looking at the last year, Z shows a quite strong growth in Revenue. The Revenue has grown by 15.52% in the last year.
  • Z shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.01% yearly.
EPS 1Y (TTM)19.71%
EPS 3Y1.9%
EPS 5Y35.43%
EPS Q2Q%44.44%
Revenue 1Y (TTM)15.52%
Revenue growth 3Y9.67%
Revenue growth 5Y-5.01%
Sales Q2Q%18.05%

3.2 Future

  • The Earnings Per Share is expected to grow by 34.13% on average over the next years. This is a very strong growth
  • The Revenue is expected to grow by 13.98% on average over the next years. This is quite good.
EPS Next Y37.61%
EPS Next 2Y34.18%
EPS Next 3Y32.83%
EPS Next 5Y34.13%
Revenue Next Year15.62%
Revenue Next 2Y14.43%
Revenue Next 3Y13.67%
Revenue Next 5Y13.98%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
Z Yearly Revenue VS EstimatesZ Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2B 4B 6B 8B
Z Yearly EPS VS EstimatesZ Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 0 2 4 6

4

4. Z Valuation Analysis

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 24.66 indicates a rather expensive valuation of Z.
  • Based on the Price/Earnings ratio, Z is valued a bit cheaper than 66.13% of the companies in the same industry.
  • Z's Price/Earnings ratio indicates a similar valuation than the S&P500 average which is at 24.89.
  • The Price/Forward Earnings ratio is 17.92, which indicates a rather expensive current valuation of Z.
  • Based on the Price/Forward Earnings ratio, Z is valued a bit cheaper than 79.03% of the companies in the same industry.
  • Z is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 22.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 24.66
Fwd PE 17.92
Z Price Earnings VS Forward Price EarningsZ Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80

4.2 Price Multiples

  • Z's Enterprise Value to EBITDA ratio is in line with the industry average.
  • Z's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 96.07
EV/EBITDA 33.97
Z Per share dataZ EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20

4.3 Compensation for Growth

  • The low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
  • Z's earnings are expected to grow with 32.83% in the coming years. This may justify a more expensive valuation.
PEG (NY)0.66
PEG (5Y)0.7
EPS Next 2Y34.18%
EPS Next 3Y32.83%

0

5. Z Dividend Analysis

5.1 Amount

  • No dividends for Z!.
Industry RankSector Rank
Dividend Yield 0%

Z Fundamentals: All Metrics, Ratios and Statistics

ZILLOW GROUP INC - C

NASDAQ:Z (3/27/2026, 8:00:03 PM)

After market: 40.56 +0.12 (+0.3%)

40.44

-1.42 (-3.39%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryReal Estate Management & Development
Earnings (Last)02-10
Earnings (Next)05-05
Inst Owners97.12%
Inst Owner Change-0.24%
Ins Owners6.51%
Ins Owner Change4.72%
Market Cap9.70B
Revenue(TTM)2.58B
Net Income(TTM)23.00M
Analysts74.67
Price Target76.5 (89.17%)
Short Float %6.8%
Short Ratio2.61
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-2.12%
Min EPS beat(2)-4.41%
Max EPS beat(2)0.18%
EPS beat(4)2
Avg EPS beat(4)-0.76%
Min EPS beat(4)-7.26%
Max EPS beat(4)8.47%
EPS beat(8)5
Avg EPS beat(8)6.73%
EPS beat(12)9
Avg EPS beat(12)38.85%
EPS beat(16)13
Avg EPS beat(16)84.33%
Revenue beat(2)0
Avg Revenue beat(2)-1.31%
Min Revenue beat(2)-1.43%
Max Revenue beat(2)-1.18%
Revenue beat(4)0
Avg Revenue beat(4)-0.92%
Min Revenue beat(4)-1.43%
Max Revenue beat(4)-0.3%
Revenue beat(8)3
Avg Revenue beat(8)0.61%
Revenue beat(12)7
Avg Revenue beat(12)1.87%
Revenue beat(16)9
Avg Revenue beat(16)-6.6%
PT rev (1m)-12.82%
PT rev (3m)-13.07%
EPS NQ rev (1m)-5.36%
EPS NQ rev (3m)-5.03%
EPS NY rev (1m)0.31%
EPS NY rev (3m)0.23%
Revenue NQ rev (1m)1.98%
Revenue NQ rev (3m)2.02%
Revenue NY rev (1m)1.06%
Revenue NY rev (3m)1%
Valuation
Industry RankSector Rank
PE 24.66
Fwd PE 17.92
P/S 3.76
P/FCF 96.07
P/OCF 26.37
P/B 1.99
P/tB 5.44
EV/EBITDA 33.97
EPS(TTM)1.64
EY4.06%
EPS(NY)2.26
Fwd EY5.58%
FCF(TTM)0.42
FCFY1.04%
OCF(TTM)1.53
OCFY3.79%
SpS10.77
BVpS20.36
TBVpS7.43
PEG (NY)0.66
PEG (5Y)0.7
Graham Number27.41
Profitability
Industry RankSector Rank
ROA 0.4%
ROE 0.47%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) 0.89%
GM 74.14%
FCFM 3.91%
ROA(3y)-1.3%
ROA(5y)-2.07%
ROE(3y)-1.78%
ROE(5y)-3.49%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-3.19%
GM growth 5Y9.35%
F-Score8
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.07
Debt/FCF 3.6
Debt/EBITDA 1.57
Cap/Depr 101.14%
Cap/Sales 10.34%
Interest Coverage N/A
Cash Conversion 158.62%
Profit Quality 439.13%
Current Ratio 3.13
Quick Ratio 3.13
Altman-Z 7.55
F-Score8
WACC8.81%
ROIC/WACCN/A
Cap/Depr(3y)81.29%
Cap/Depr(5y)78.02%
Cap/Sales(3y)8.82%
Cap/Sales(5y)6.98%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)19.71%
EPS 3Y1.9%
EPS 5Y35.43%
EPS Q2Q%44.44%
EPS Next Y37.61%
EPS Next 2Y34.18%
EPS Next 3Y32.83%
EPS Next 5Y34.13%
Revenue 1Y (TTM)15.52%
Revenue growth 3Y9.67%
Revenue growth 5Y-5.01%
Sales Q2Q%18.05%
Revenue Next Year15.62%
Revenue Next 2Y14.43%
Revenue Next 3Y13.67%
Revenue Next 5Y13.98%
EBIT growth 1Y83.16%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1906.75%
EBIT Next 3Y211.5%
EBIT Next 5Y112.51%
FCF growth 1Y-60.7%
FCF growth 3Y-71.5%
FCF growth 5Y-20.38%
OCF growth 1Y-14.02%
OCF growth 3Y-56.61%
OCF growth 5Y-2.8%

ZILLOW GROUP INC - C / Z Fundamental Analysis FAQ

What is the ChartMill fundamental rating of ZILLOW GROUP INC - C (Z) stock?

ChartMill assigns a fundamental rating of 5 / 10 to Z.


What is the valuation status of ZILLOW GROUP INC - C (Z) stock?

ChartMill assigns a valuation rating of 5 / 10 to ZILLOW GROUP INC - C (Z). This can be considered as Fairly Valued.


What is the profitability of Z stock?

ZILLOW GROUP INC - C (Z) has a profitability rating of 3 / 10.


Can you provide the PE and PB ratios for Z stock?

The Price/Earnings (PE) ratio for ZILLOW GROUP INC - C (Z) is 24.66 and the Price/Book (PB) ratio is 1.99.


What is the financial health of ZILLOW GROUP INC - C (Z) stock?

The financial health rating of ZILLOW GROUP INC - C (Z) is 8 / 10.